Some of the genetic risk can be explained by pathogenic variants in other BC susceptibility genes, including TP53, CDH1, PALB2, and PTEN, and various rare gene variants have also been reported to increase the risk of developing BC [73,74]. The gene discussed is PALB2; the disease is breast cancer.